#TALK Research - August Newsletter
09/08/2024
Middlemore Hospital has a strong research culture and a proud history of engagement and success in research across many therapeutic areas and research types.
Read more09/08/2024
Middlemore Hospital has a strong research culture and a proud history of engagement and success in research across many therapeutic areas and research types.
Read more07/08/2024
Researchers looking to improve management strategies for prosthetic joint infections were recently awarded a $1.4 million project grant from the Health Research Council (HRC).
Read more24/07/2024
U.S.-based Care Access to leverage its renowned decentralised capabilities to expand research availability to more communities in New Zealand
Read more24/04/2024
GIP and glucagon receptor agonists has the potential to change the medical world and the effects of obesity.
Read more22/02/2024
Aotearoa Clinical Trials is working to the highest global best-practice standards.
Read more05/12/2023
GIP and glucagon receptor agonists has the potential to change the medical world and the effects of obesity.
Read more27/10/2023
Aotearoa Clinical Trials is proud to have been part of the MATISSE Trial. ABRYSVO™, Pfizer’s bivalent RSV preF vaccine for the prevention of Lower Respiratory Tract Disease (LRTD) and severe LRTD caused by RSV in infants from birth up to six months of age was approved by the FDA on 21st August 2023.
Read more24/05/2023
Aotearoa Clinical Trials Trust is pleased to announce a partnership between Aotearoa Clinical Trials (ACTT) and Te Whatu Ora, Te Tai Tokerau for the management of clinical trials based at Whangarei Hospital for the community of Te Tai Tokerau Northland.
Read more15/05/2023
Aotearoa Clinical Trial's Investigator Initiated trial offers adolescents the opportunity to improve or prevent their diabetes through weight loss and bariatric surgery.
Read more13/04/2023
As we evolve as a research unit we have to respond to the opportunities that we see.
Read more21/12/2022
We would like to share with you our plans to change the name of Middlemore Clinical Trials.
Read more